How Rodriguez was paid
$18.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Javier J. RodriguezChief Executive Officer | $1,500,000 | $11,442,481 | $2,699,982 | $2,089,491 | $478,643 | $18,210,597 |
| Joel AckermanChief Financial Officer and Treasurer | $834,616 | $3,644,589 | $860,008 | $774,063 | $16,686 | $6,129,962 |
| David P. MaughanChief Operating Officer, DaVita Kidney Care | $725,000 | $3,178,454 | $750,001 | $686,330 | $252,474 | $5,592,259 |
| Kathleen A. WatersChief Legal and Public Affairs Officer | $750,000 | $2,034,334 | $479,982 | $662,664 | $16,665 | $3,943,645 |
| James O. HeartyChief Compliance Officer | $600,000 | $720,420 | $170,012 | $455,331 | $16,352 | $1,962,115 |
What changed and why
- $21.8MCEO total compensation decreased from $21,807,489 in 2024 to $18,210,597 in 2025.
- $15.8MStock awards for the CEO decreased from $15,849,833 in 2024 to $11,442,481 in 2025.
- $2.7MOption awards for the CEO were introduced at $2,699,982 in 2025 following a zero balance in 2024.
- $4.1MNon-equity incentive plan compensation for the CEO decreased from $4,118,119 in 2024 to $2,089,491 in 2025.
- $474KOther compensation for the CEO included mandated personal aircraft travel and security costs totaling $474,413.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.